BLUMICIMENT
UNII DM6XM9P63V

Substance Identification & Data

This profile provides standardized clinical and technical data for Blumiciment, uniquely identified by the FDA Unique Ingredient Identifier (UNII) DM6XM9P63V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3075548-87-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

DM6XM9P63V

CAS Registry Number

3075548-87-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BLUMICIMENT

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

14067

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Blumiciment

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Blumiciment. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Blumiciment

Common Names & Synonyms

H-gamma4 heavy chain anti-VWF Homo sapiens hole (H) (1-452) [VH (Homo sapiens GHV1-24*01 (85.6%) -(IGHD) -IGHJ1*01 (90.9%) L123>T (121), CDR-IMGT [8.8.19] (26-33.51-58.97-115)) (1-126) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, 12-G4v5 h P10, 6-G4v4 CH2 A1.3, A1.2, 14-G4v33 CH3 S22, A24, V86 (hole), 10-G4v110 CHS delK2 (CH1 (127-224), hinge 1-12 S10>P (234) (225-236), CH2 F1.3>A (240), L1.2>A (241), L92 (315) (237-346), CH3 T22>S (372), L24>A (374), Y86>V (413) (347-451), CHS K2>del (452)) (127-452)], (140-213')-disulfide with L-kappa light chain anti-VWF Homo sapiens (1'-213') [V-KAPPA (Homo sapiens IGKV1-9*03 (89.9%) -IGKJ4*01 (91.7%), CDR-IMGT [6.3.8] (27'-32'.50'-52'.89'-96')) (1'-106') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (152'), V101 (190') (107'-213')]; G4(hCH2CH3) chain Homo sapiens knob (H'') (1''-228'') [Homo sapiens IGHG4*01, nG4m(a) CH2 L92, 12-G4v5 h P10, 6-G4v4 CH2 A1.3, A1.2, 14-G4v32 CH3 W22 (knob), 10-G4v110 CHS delK2 (hinge 1-12 S10>P (10'') (1''-12''), CH2 F1.3>A (16''), L1.2>A (17''), L92 (91'') (13''-122''), CH3 T22>W (148'') (123''-227''), CHS K2>del (228''))]; dimer (232-8'':235-11'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1SV, lacking the glutamine synthetase (GSKO) gene, glycoform alfa

Immunoglobulin G4 [234-proline,240-alanine,241-alanine,372-serine,374-alanine,413-valine,de-453-lysine], anti-(human/Macaca fascicularis/Oryctolagus cuniculus/Sus scrofa domesticus von Willebrand factor) (human monoclonal HMB-002 γ4-chain) disulfide with human monoclonal HMB-002 κ-chain, (232→8′),(235→11′)-bis(disulfide) with immunoglobulin G4 [10-proline,16-alanine,17-alanine,148-tryptophan,de-229-lysine] (human γ4-chain hinge-CH2-CH3 fragment)

blumiciment [INN]

immunoglobulin (H-gamma4_L-kappa)_G4(hCH2CH3), anti-[Homo sapiens VWF (von Willebrand factor) C-terminal cystine knot (CTCK) domain], Homo sapiens monoclonal antibody (blumiciment)

Technical Codes

HMB-002

HMB002

External Clinical & Regulatory Resources

Previous UNIIDM6KB19CL7

Next UNIIDM6ZRH9TES